Duncan Mckechnie sold $800K of VRTX stock

Duncan Mckechnie, EVP, Chief Commercial Officer of Vertex Pharmaceuticals Inc / Ma (VRTX), sold 1,541 shares of VRTX stock worth $800K, per an SEC Form 4 filed Jul 7, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jul 2, 2026, 5 days before it was made public.

VRTX has moved +3.6% since the trade date, from $528.04 to $547.03 (Nov 11, 2026 close).